findmyKOL

Michael Rickels, MD

Enriched profile

Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases; Director of Clinical Science, Division of Endocrinology, Diabetes & Metabolism · University of Pennsylvania Perelman School of Medicine

ORCIDNPI
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusDiabetes Management and Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2004–2026

Michael Rickels is Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases; Director of Clinical Science, Division of Endocrinology, Diabetes & Metabolism at University of Pennsylvania Perelman School of Medicine. OpenAlex indexes 324 publications with 16,730 citations (h-index 61); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Michael Rickels, MD, is Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases at University of Pennsylvania Perelman School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes & Metabolism. The public record shows 324 publications with 16,730 citations (h-index 61), centered on Diabetes Management and Research, Pancreatic function and diabetes, Diabetes and associated disorders. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 7 companies, 7 NIH-funded awards (2004–2026).

  • Most recent indexed publication: 2026 · Diabetes care
  • Top research focus: Diabetes Management and Research
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cystic Fibrosis4 trialsType 1 Diabetes4 trialsCysts4 trialsHypoglycemia3 trialsExocrine Pancreatic Insufficiency3 trialsType 2 Diabetes1 trial

Research focus

OpenAlex concept fingerprint
Diabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disordersDiabetes Treatment and ManagementCystic Fibrosis Research Advances

Drugs & molecules

across trials, industry payments and publications
Zegaloguegeneric · DasiglucagonClinical trialsIndustry payments12Publications

Works with

trial sponsors and companies reporting payments
Vertex Pharmaceuticals IncorporatedClinical trialsIndustry payments34Zealand Pharma US, Inc.Clinical trialsIndustry payments12University of PennsylvaniaClinical trials7Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
324publications

Distinct works indexed by OpenAlex, matched via ORCID; 48 in PubMed.

16,730citations

Total citations across indexed works.

61h-index

Hirsch index (OpenAlex). i10-index 163.

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials
7companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
7NIH grants · 2004–2026

Federally funded research awards.

View funding

Public positions

sourced statements on record
  • Chair

    Metabolics Study Subcommittee, NIH-sponsored Clinical Islet Transplantation Consortium

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • Chair

    Publications and Presentations Committee, NIH-sponsored Collaborative Islet Transplant Registry (CITR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    61%
    Biguanide (metformin)24.5%
    Metformin Hcl Er61%Metformin Hcl39%
    Part D<11 patients
    Insulin Analog19%
    Lantus Solostar50%Novolog Flexpen50%
    Part D<11 patients
  • Cardiovascular

    23%
    Statin17%
    Atorvastatin Calcium68%Rosuvastatin Calcium32%
    Part D<11 patients
    Cholesterol absorption inhibitor6%
    Ezetimibe100%
    Part D<11 patients
  • Hormonal (systemic)

    9.5%
    l-Thyroxine9.5%
    Levothyroxine Sodium100%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

7 NIH research awards on record, funded 20042026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

49 congress contributions (2015–2025) across ADA, ENDO per OpenAlex. The most recent:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Amy J. Peleckis46Roy W. Beck42Ali Naji42

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    diabetesjournals.org/care/article/47/9/1466/157109/About-the-Editor-Michael-R-Rickels-MD-MS-Guiding

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org
  • ResearchGate

    researchgate.net/scientific-contributions/Michael-R-Rickels-38904196

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • LinkedIn

    LinkedIn profile: Michael Rickels - Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases - University of Pennsylvania School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • Doximity

    Doximity profile: Dr. Michael Rickels, MD - Philadelphia, PA - Endocrinology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.S.

    Translational Research, University of Pennsylvania School of Medicine

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • M.D.

    University of Pennsylvania School of Medicine, 1999 (top of class)

    1999
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • B.A.

    Mathematics and Biology (Summa Cum Laude), Colgate University

    1995
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Pancreatic Islet Cell Transplantation Program, Hospital of the University of Pennsylvania

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • Director

    Translational Research, Institute for Diabetes, Obesity & Metabolism, University of Pennsylvania

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
  • Director

    Radioimmunoassay and Biomarkers Core, Penn Diabetes Research Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • Guest

    DiabetesBio podcast (May 2025) discussing beta-cell secretory capacity and metabolic outcomes after human islet transplantation

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →music.amazon.com
  • Co-host

    "Diabetes Care On Air" podcast (American Diabetes Association), launched January 2024, with Alice Cheng, MD

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.